[HTML][HTML] Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
T Maruhashi, D Sugiura, I Okazaki, K Shimizu… - Immunity, 2022 - cell.com
Summary Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, its
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
[HTML][HTML] Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
T Maruhashi, D Sugiura, I Okazaki, K Shimizu… - Immunity, 2022 - cell.com
Summary Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, its
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
[引用][C] Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
T Maruhashi, D Sugiura, I Okazaki, K Shimizu… - Immunity, 2022 - cir.nii.ac.jp
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses
autoimmunity and anti-cancer immunity | CiNii Research CiNii 国立情報学研究所 学術情報 …
autoimmunity and anti-cancer immunity | CiNii Research CiNii 国立情報学研究所 学術情報 …
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity.
T Maruhashi, D Sugiura, IM Okazaki, K Shimizu… - Immunity, 2022 - europepmc.org
Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, its functional
ligand remains elusive, with distinct potential ligands identified. Here, we investigated the …
ligand remains elusive, with distinct potential ligands identified. Here, we investigated the …
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
T Maruhashi, D Sugiura, I mi Okazaki… - …, 2022 - kyushu-u.elsevierpure.com
Abstract Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, its
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
[HTML][HTML] Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
T Maruhashi, D Sugiura, I Okazaki, K Shimizu… - Immunity, 2022 - Elsevier
Summary Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, its
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
functional ligand remains elusive, with distinct potential ligands identified. Here, we …
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
T Maruhashi, D Sugiura, IM Okazaki, K Shimizu… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, its functional
ligand remains elusive, with distinct potential ligands identified. Here, we investigated the …
ligand remains elusive, with distinct potential ligands identified. Here, we investigated the …
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
T Maruhashi, D Sugiura, I Okazaki, K Shimizu… - paper.sciencenet.cn
Lymphocyte activation gene-3 (LAG-3) is a potent inhibitory co-receptor; yet, itsfunctional
ligand remains elusive, with distinct potential ligands identified. Here, we investigated the …
ligand remains elusive, with distinct potential ligands identified. Here, we investigated the …